603456.SH
九洲药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 15.71
−5.36%Sep 3, 2026, 10:16 UTC
Jiuzhou Pharmaceutical's wholly-owned subsidiary Jiuzhou Biomedicine (Taizhou) received drug registration certificates from China's National Medical Products Administration for its buspirone citrate tablets in 5mg and 10mg strengths.
Source:Aug 16, 2026, 13:57 UTC
Jiuzhou Pharmaceutical disclosed that its CDMO business new orders grew steadily in H1 2026, adding 66 early-stage clinical projects, 5 Phase III-to-pre-launch projects, and 5 commercial projects.
Jul 6, 2026, 09:20 UTC
Jiuzhou Pharmaceutical cancels 7.736 million repurchased shares on July 7, reducing total share capital from 889 million to 882 million shares.
Source: